AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
Log in

CVE:MNXManitex Capital Stock Price, Forecast & News

C$0.29
-0.01 (-1.69 %)
(As of 06/3/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.29
Now: C$0.29
C$0.30
50-Day Range
C$0.14
MA: C$0.23
C$0.25
52-Week Range
C$0.15
Now: C$0.29
C$0.30
Volume30,500 shs
Average Volume15,292 shs
Market CapitalizationC$3.64 million
P/E Ratio0.38
Dividend YieldN/A
BetaN/A
Manitex Capital Inc., through its subsidiary, Valeo Pharma Inc., acquires and markets specialty pharmaceutical products, and distributes third-party pharmaceutical products primarily in Canada. It operates through two segments, Investments and Pharmaceutical. The company sells its products through wholesalers and retail pharmacy chains, as well as through hospitals and other groups. It also invests in marketable securities, as well as provides consulting services for private companies. Manitex Capital Inc. is headquartered in Kirkland, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.90 out of 5 stars


Industry, Sector and Symbol

Industry Medical Distribution
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
WebN/A
Phone514-693-8844

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$4.38 million
Cash FlowC$0.29 per share
Book ValueC$1.29 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$3.64 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MNX News and Ratings via Email

Sign-up to receive the latest news and ratings for MNX and its competitors with MarketBeat's FREE daily newsletter.

Manitex Capital (CVE:MNX) Frequently Asked Questions

Has Manitex Capital been receiving favorable news coverage?

News stories about MNX stock have trended somewhat positive recently, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Manitex Capital earned a media sentiment score of 0.9 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutManitex Capital.

Who are some of Manitex Capital's key competitors?

Who are Manitex Capital's key executives?

Manitex Capital's management team includes the following people:
  • Mr. Steven Saviuk, Chairman, Pres & CEO (Age 60)
  • Ms. Helen Saviuk, CFO & Director
  • Mr. Ronald S. Perry CA, CPA, Sec. & Independent Director (Age 63)
  • Mr. Marc Leger, Exec. VP of Commercial Operations - Valeo Pharma Inc
  • Nathalie Therrien, Vice-Pres of QA & Regulatory Affairs - Valeo Pharma Inc.

What is Manitex Capital's stock symbol?

Manitex Capital trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MNX."

How do I buy shares of Manitex Capital?

Shares of MNX and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Manitex Capital's stock price today?

One share of MNX stock can currently be purchased for approximately C$0.29.

How big of a company is Manitex Capital?

Manitex Capital has a market capitalization of C$3.64 million and generates C$4.38 million in revenue each year.

How can I contact Manitex Capital?

The company can be reached via phone at 514-693-8844.

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.